|
Volumn 113, Issue 18, 2009, Pages 4478-
|
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 (Blood (2008) 111, (4477-4489))
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERRATUM;
ERROR;
PRIORITY JOURNAL;
|
EID: 70449449309
PISSN: 00064971
EISSN: 15280020
Source Type: None
DOI: 10.1182/blood-2009-03-210906 Document Type: Erratum |
Times cited : (5)
|
References (0)
|